Herbalife (HLF) Price Target Reduced to $75 at Pivotal Research
Pivotal Research maintained a Buy rating on Herbalife (NYSE: HLF) and lowered its price target to $75.00 (from $110.00). The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)